$17.050
-0.198 (-1.16%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CTNM Prediction & Forecast by Similar Chart Analysis
Alphio's CTNM stock price prediction model matches the current Contineum Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.26 (+1.26%). The 1-week path is $17.48 (+2.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Contineum Therapeutics Inc Stock?
Contineum Therapeutics Inc is a good buy right now due to its current price of $17.05, which is below the analyst price target of $24, indicating significant upside potential. Additionally, the company has a strong liquidity position with $236.6 million in cash, which allows it to fund operations through mid-2029 despite ongoing losses. The RSI is at 66.187, suggesting that the stock is in a strong momentum phase, and the recent positive trial results for PIPE-791 may drive future growth. However, the main risk is the negative earnings trend, with a projected EPS of -0.40 for Q2 2026, which could affect investor sentiment.
CTNM stock price ended at $17.05 on Friday, after losing -1.16%
Contineum Therapeutics Inc (CTNM) last closed at $17.05, losing -1.16%. These facts feed the 1-day and 1-week CTNM price prediction above.
Forecast Drivers
Contineum Therapeutics Inc (CTNM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CTNM, ranked by similarity.
Seasonality analysis for CTNM
Historically the probability of a positive August return for CTNM is 66.67%. July offers the highest probability of a positive month at 66.67%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CTNM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.87 | $4.25 | $4.61 | -75.05% |
| Sep 2026 | $4.42 | $4.44 | $4.81 | -73.98% |
| Oct 2026 | $3.06 | $3.88 | $4.41 | -77.23% |
| Nov 2026 | $3.08 | $3.92 | $3.98 | -77.03% |
| Dec 2026 | $3.75 | $4.57 | $4.88 | -73.21% |
In 2026, Contineum Therapeutics Inc (CTNM) is projected to range from $3.06 to $4.88.
Contineum Therapeutics Inc 2026 monthly forecast
In Aug 2026, Contineum Therapeutics Inc is projected to average $4.25, with a low of $3.87 and high of $4.61.
In Sep 2026, Contineum Therapeutics Inc is projected to average $4.44, with a low of $4.42 and high of $4.81.
In Oct 2026, Contineum Therapeutics Inc is projected to average $3.88, with a low of $3.06 and high of $4.41.
In Nov 2026, Contineum Therapeutics Inc is projected to average $3.92, with a low of $3.08 and high of $3.98.
In Dec 2026, Contineum Therapeutics Inc is projected to average $4.57, with a low of $3.75 and high of $4.88.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.